When we analysed the site of tumor cell injection by immune-histochemical stainings 21 days after injection we found residual tumor cells that displayed no signs of proliferation upon stable shRNA knockdown for CDK4 and CDK6 when compared to controls (Figure 4B). Here, CDK6 is linked to neoplasm.